Case study: Better, faster method development at Janssen
Posted: 30 June 2020 | ACD/Labs | No comments yet
Learn how method development software helped Janssen Pharmaceuticals reduce method development time by 80% with a 25-fold increase in method quality
Combining advanced hardware and software with a scientific strategy significantly improved the time and quality of method development for impurity identification at Janssen. These twin goals were achieved through a methodical approach to help scientists create robust, repeatable methods following QbD and DoE principles. Scientists found that investing in software and automating manual operations reduced the data evaluation burden and increased both efficiency and method quality.
Related content from this organisation
- On-demand webinar: How to be a spectral superstar – NMR & MS analysis made easy
- On-demand webinar: Practical considerations for improving high throughput synthesis
- Case study: Takeda streamline analytical handling
- Case study: Better, faster method development at Janssen
- Application note: Tracking the fate and purge of impurities
Related topics
Analytical techniques, Biopharmaceuticals, Hit-to-Lead, Informatics, Mass Spectrometry, Spectroscopy
Related organisations
ACD/Labs
